Copyright: ©Author(s) 2026.
World J Orthop. Mar 18, 2026; 17(3): 115251
Published online Mar 18, 2026. doi: 10.5312/wjo.v17.i3.115251
Published online Mar 18, 2026. doi: 10.5312/wjo.v17.i3.115251
Table 1 General information of the two groups of children, mean ± SD
| Gender | Affected side | Treatment age (months) | Average follow-up (months) | Last follow-up age (months) | Last follow-up height (cm) | Last follow-up weight (kg) | |||
| Male | Female | Left | Right | ||||||
| CR group | 4 | 24 | 20 | 8 | 14.96 ± 6.94 | 51.64 ± 34.85 | 66.86 ± 34.56 | 112.89 ± 18.09 | 21.71 ± 11.15 |
| Salter group (n = 31) | 7 | 24 | 19 | 12 | 35.52 ± 16.20a | 51.0 ± 34.76 | 85.35 ± 38.78a | 121.71 ± 20.32 | 25.06 ± 11.83 |
Table 2 Comparison of surface electromyography signals of the affected and healthy lower limbs of the 2 groups of children when standing, median (25th percentile-75th percentile)
| Closed reduction group | Salter osteotomy group | |||||||||
| Affected side | Healthy side | The ratio of the affected side to the healthy side | Affected side CCR | Healthy side CCR | Affected side | Healthy side | The ratio of the affected side to the healthy side | Affected side CCR | Healthy side CCR | |
| Tensor fasciae latae | 3.62 (1.93-6.02) | 3.92 (2.11-5.78) | 0.91 (0.64-1.23) | 0.61 (0.49-0.76) | 0.64 (0.52-0.76) | 4.66 (2.91-7.51) | 3.85 (2.42-6.98) | 1.18 (0.80-1.81) | 0.68 (0.57-0.81) | 0.62 (0.48-0.76) |
| Gluteus maximus | 1.49 (1.21-2.61) | 1.75 (1.22-2.52) | 0.97 (0.84-1.24) | 2.00 (1.47-2.24) | 1.96 (1.32-3.81) | 1.04 (0.59-1.47) | ||||
| Rectus femoris | 1.92 (1.09-4.74) | 2.64 (1.18-3.97) | 0.91 (0.80-1.26) | 0.25 (0.11-0.44) | 0.22 (0.18-0.42) | 2.18 (1.60-6.55) | 2.31 (1.43-6.85) | 0.95 (0.68-1.32) | 0.33 (0.15-0.60) | 0.36 (0.16-0.54) |
| Hamstring muscles | 6.55 (3.17-13.82) | 8.94 (3.37-12.51) | 0.94 (0.73-1.37) | 5.39 (3.69-12.29) | 7.08 (2.25-13.54) | 0.99 (0.60-1.31) | ||||
| Tibialis anterior muscle | 4.97 (2.03-10.40) | 4.71 (2.01-10.78) | 0.99 (0.81-1.23) | 0.40 (0.30-0.56) | 0.44 (0.32-0.55) | 4.98 (3.53-7.32) | 4.58 (2.15-8.93) | 0.99 (0.81-1.12) | 0.47 (0.37-0.60) | 0.49 (0.28-0.58) |
| Musculus gastrocnemius | 5.75 (3.20-9.28) | 5.60 (3.99-8.47) | 0.99 (0.86-1.23) | 4.44 (3.53-7.32) | 6.14 (3.86-8.75) | 0.93 (0.85-1.05) | ||||
Table 3 Comparison of surface electromyography signals of the affected and healthy lower limb muscles during walking in the 2 groups of children, median (25th percentile-75th percentile)
| Closed reduction group | Salter osteotomy group | |||||||||
| Affected side RMS | Healthy side RMS | RMS the ratio of the affected side to the healthy side | Affected side CCR | Healthy side CCR | Affected side RMS | Healthy side RMS | RMS the ratio of the affected side to the healthy side | Affected side CCR | Healthy side CCR | |
| Tensor fasciae latae | 35.71 (28.15-54.12) | 31.60 (24.05-49.63) | 1.06 (0.91-1.32) | 0.78 (0.67-0.85) | 0.78 (0.69-0.83) | 49.31 (32.33-73.58)a | 44.17 (28.94-66.38)a | 1.21 (0.83-1.43) | 0.82 (0.75-0.87) | 0.78 (0.75-0.83) |
| Gluteus maximus | 12.57 (6.61-17.96) | 11.01 (6.73-16.73) | 0.97 (0.86-1.11) | 11.04 (6.52-15.75) | 14.64 (7.44-18.98) | 0.88 (0.75-1.14) | ||||
| Rectus femoris | 18.33 (14.44-27.31) | 21.75 (15.57-28.71) | 1.01 (0.77-1.14) | 0.46 (0.37-0.52) | 0.46 (0.37-0.56) | 27.36 (19.24-37.04)a | 25.20 (17.81-28.91) | 1.06 (0.82-1.59) | 0.54 (0.46-0.65)a | 0.51 (0.38-0.56) |
| Hamstring muscles | 23.77 (15.42-33.71) | 23.57 (17.73-36.53) | 0.95 (0.79-1.12) | 22.81 (16.25-30.26) | 22.64 (19.13-34.34) | 0.87 (0.73-1.12) | ||||
| Tibialis anterior muscle | 38.44 (31.50-50.36) | 37.43 (28.64-45.24) | 1.02 (0.89-1.18) | 0.48 (0.43-0.55) | 0.47 (0.41-0.56) | 39.05 (17.71-55.28) | 39.07 (19.24-50.23) | 0.99 (0.86-1.16) | 0.53 (0.43-0.58) | 0.54 (0.43-0.59) |
| Musculus gastrocnemius | 37.43 (30.52-52.19) | 39.00 (29.82-58.29) | 0.99 (0.88-1.12) | 34.57 (23.70-47.55) | 36.65 (25.49-47.08) | 1.05 (0.92-1.15) | ||||
- Citation: Li X, Ma SH, Gong HL, Wen J, Li FL, Xiao S. Surface electromyography signal characteristics of lower limb muscles in children with unilateral developmental dysplasia of the hip. World J Orthop 2026; 17(3): 115251
- URL: https://www.wjgnet.com/2218-5836/full/v17/i3/115251.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i3.115251
